Company Filing History:
Years Active: 2024-2025
Title: Innovations by Ricardo Carl Elciario Dolmetsch
Introduction
Ricardo Carl Elciario Dolmetsch is an accomplished inventor based in Concord, MA, known for his significant contributions to the field of pharmacology. He holds two patents that focus on the use of mavoglurant in treating substance use disorders. His work aims to provide innovative solutions for individuals struggling with alcohol and cocaine use disorders.
Latest Patents
Dolmetsch's latest patents include the use of mavoglurant in the reduction of alcohol use and in preventing relapse into alcohol use. This invention relates to the application of mavoglurant, or a pharmaceutically acceptable salt thereof, to help patients with alcohol use disorder reduce their alcohol consumption, prevent relapse, and promote abstinence. Additionally, he has developed a patent for the use of mavoglurant in the reduction of cocaine use and in preventing relapse into cocaine use. This invention similarly focuses on aiding patients with cocaine use disorder in reducing their cocaine consumption and managing associated symptoms of depression or anxiety.
Career Highlights
Dolmetsch is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further his research and development efforts in the field of addiction treatment. His innovative approaches have the potential to significantly impact the lives of individuals facing substance use disorders.
Collaborations
Dolmetsch has collaborated with notable colleagues, including Fabrizio Gasparini and Baltazar Gomez-Mancilla. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Ricardo Carl Elciario Dolmetsch is a prominent inventor whose work in pharmacology addresses critical issues related to substance use disorders. His innovative patents demonstrate a commitment to improving treatment options for individuals struggling with addiction.